“Pharmaco-Metabonomics” Holds Promise for Personalized Drug Therapies, Researchers Say
This article was originally published in The Pink Sheet Daily
The method uses a combination of advanced chemical analysis and mathematical modeling to predict drug response.
You may also be interested in...
More than one in four National Cancer Institute-funded scientists start their own healthcare companies based on their own discoveries.
U.S. overtakes Europe in innovation between 1993 and 2003, introducing the most first-in-class, biotech and orphan products in the global market, according to a study authored by a Duke University economics professor
The resource, patientINFORM, will offer “relevant” research articles free to the public immediately after publication and in their final, edited form.